News
ROTOP Pharmaka Welcomes State Minister Dirk Panter: Radiopharmacy as a Key Technology in Modern Cancer Care
January 9, 2026 - ROTOP Pharmaka welcomed Saxony’s State Minister Dirk Panter during the region’s Radiopharmacy Theme Day. The exchange highlighted the importance of modern radiopharmacy for cancer care as well as ROTOP’s contribution through diagnostics, ready to use patient doses, and CDMO services, with a particular focus on theranostic concepts.
ROTOP featured in VentureCapital Magazine
We are delighted to be featured in the latest issue of VentureCapital Magazine, which spotlights the Dresden region as a high-performance hub for key
New Milestone: RoTecPSMA® Approved in Switzerland
RoTecPSMA® Approved in Switzerland – Expanding Access to Advanced Prostate Cancer Diagnostics We are delighted to announce that RoTecPSMA® has received marketing authorization in
Team ROTOP is back from SNMMI 2025 in New Orleans
Team ROTOP is back from SNMMI 2025 in New Orleans and feels energized by the global momentum in radiopharmaceuticals. Team ROTOP - Jens Junker,
First marketing authorization for RoTecPSMA®
First marketing authorization for RoTecPSMA® We are thrilled to announce that RoTecPSMA® has been approved in the United Kingdom! RoTecPSMA® is a technetium-99m cold
ROTOP Pharmaka GmbH Announces Investments from GENUI & SHS Capital and New President, ROTOP USA.
Andrew Varghese, President USA ROTOP Pharmaka GmbH ROTOP Pharmaka GmbH is pleased to announce new investments secured from GENUI & SHS Capital along